Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F0WF4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,508
Award facts
- Contract value 100% obligated
- $12,508.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,508.06 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price contract represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company supplies a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military and veteran healthcare systems, including specialty medications, branded and generic drugs, vaccines, and medical devices. As the prime contractor under the SPE2DX IDC, AmerisourceBergen Drug Corp demonstrates significant capability in fulfilling federal procurement requirements through competitive processes, with contract awards ranging from nominal transactions to orders exceeding $45,000, enabling it to serve critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F0WF4?
SPE2DR26F0WF4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F0WF4 worth?
The government has obligated $12,508 on SPE2DR26F0WF4.
Is contract SPE2DR26F0WF4 an order under another contract?
Yes. SPE2DR26F0WF4 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WF4 competed?
The extent of competition for SPE2DR26F0WF4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award